Skip to main content
DeutschDE
European Commission logo print header

Hijacking cell signalling pathways with magnetic nanoactuators for remote-controlled stem cell therapies of neurodegenerative disorders

Ziel

Neurodegenerative diseases, such as Parkinson’s disease, are a major public health issue given the aging population in
Europe and beyond. While curative pharmacological treatment of these diseases is not in sight, cell replacement therapies
(CTs) are considered very promising, in particular with the advent of stem-cell reprogramming technologies. However, a
fundamental challenge in the medical application of CTs in the brain of patients lies in the lack of control of cell behaviour at
the site of transplantation, and particularly their differentiation and oriented growth. The aim of this project is to introduce a
fundamentally new concept for remote control of cellular functions by means of magnetic manipulation. The technology is
based on magnetic nanoparticles functionalized with proteins involved in cellular signalling cascades. These
biofunctionalized MNPs (bMNPs) will be delivered into target cells, where they act as intracellular signalling platforms
activatable in a spatially and temporally controlled manner by external magnetic fields. The project will focus on engineering
these tools for the control of neuronal cell programming and fibre outgrowth by hijacking Wnt and neurotrophin signalling,
respectively, with the ulti-mate objective of advancing cell replacement therapies for PD using dopaminergic precursor
neurons.
To achieve this ambitious goal, we have gathered an interdisciplinary consortium interfacing scientists having cutting-edge
know-how in bMNP engineering, surface functionalization and cellular nanobiophysics with renowned experts in neuronal
cell differentiation, stem-cell reprogramming and regenerative (nano-)medicine. By exploiting this complementary expertise,
a novel, versatile technology for magnetic control of intracellular signalling is envis-aged, which will be a breakthrough for
remote actuation of cellular functions and its successful implementation in CTs for neurodegenerative diseases and injuries
within the following decade.

Wissenschaftliches Gebiet

Programm/Programme

Thema/Themen

Aufforderung zur Vorschlagseinreichung

H2020-FETOPEN-2014-2015

Andere Projekte für diesen Aufruf anzeigen

Unterauftrag

H2020-FETOPEN-2014-2015-RIA

Finanzierungsplan

RIA - Research and Innovation action

Koordinator

INSTITUT CURIE
Netto-EU-Beitrag
€ 638 750,00
Adresse
RUE D ULM 26
75231 Paris
Frankreich

Auf der Karte ansehen
Region
Ile-de-France Ile-de-France Paris
Aktivitätstyp
Research Organisations
Links
Gesamtkosten
€ 638 750,00

Beteiligte (7)

Diese Seite teilen

Herunterladen

Letzte Aktualisierung: 3 September 2022

Mein Booklet

Permalink: https://cordis.europa.eu/project/id/686841/de

European Union, 2024